Dare Bioscience, Inc. (DARE): Capital Expenditures
$385.3K
Year ended 2025-12-31
$461.9K
Trailing 12 months to 2026-06-30
+82.8%
3-year compound annual growth
+85.3%
5-year compound annual growth
+3.4%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $385.3K | -32.8% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $573.0K | -9.0% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $629.4K | +898.0% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $63.1K | +334.2% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $14.5K | -17.6% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $17.6K | n/a | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $0 | -100.0% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $11.8K | n/a | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | $0 | -100.0% | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $535.0K | +93.1% | 2017-06-13, From 2016-01-01 |
| 2015-12-31 | $277.0K | +23.1% | 2017-06-13, From 2015-01-01 |
| 2014-12-31 | $225.0K | n/m | 2017-06-13, From 2014-01-01 |
| 2013-12-31 | $7.0K | -96.1% | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | $180.0K | n/a | 2015-03-19, From 2012-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $385.3K | -32.8% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $139.9K | +34.8% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $71.0K | +20.3% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $600.0K | n/a |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2025-03-31 | $2.0K | -71.4% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $4.0K | -97.2% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $245.0K | -62.6% |
| Rallybio Corp (RLYB) | 2024-12-31 | $0 | -100.0% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $112.0K | -18.8% |
Compare DARE, SXTP, STTK, BSPK side by side · Screen every company in Pharmaceutical Preparations ↗